Literature DB >> 16916915

Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis.

Leigh A Callahan1, Gerald S Supinski.   

Abstract

Previous studies indicate that ATP formation by the electron transport chain is impaired in sepsis. However, it is not known whether sepsis affects the mitochondrial ATP transport system. We hypothesized that sepsis inactivates the mitochondrial creatine kinase (MtCK)-high energy phosphate transport system. To examine this issue, we assessed the effects of endotoxin administration on mitochondrial membrane-bound creatine kinase, an important trans-mitochondrial ATP transport system. Diaphragms and hearts were isolated from control (n = 12) and endotoxin-treated (8 mg.kg(-1).day(-1); n = 13) rats after pentobarbital anesthesia. We isolated mitochondria using techniques that allow evaluation of the functional coupling of mitochondrial creatine kinase MtCK activity to oxidative phosphorylation. MtCK functional activity was established by 1) determining ATP/creatine-stimulated oxygen consumption and 2) assessing total creatine kinase activity in mitochondria using an enzyme-linked assay. We examined MtCK protein content using Western blots. Endotoxin markedly reduced diaphragm and cardiac MtCK activity, as determined both by ATP/creatine-stimulated oxygen consumption and by the enzyme-linked assay (e.g., ATP/creatine-stimulated mitochondrial respiration was 173.8 +/- 7.3, 60.5 +/- 9.3, 210.7 +/- 18.9, was 67.9 +/- 7.3 natoms O.min(-1).mg(-1) in diaphragm control, diaphragm septic, cardiac control, and cardiac septic samples, respectively; P < 0.001 for each tissue comparison). Endotoxin also reduced diaphragm and cardiac MtCK protein levels (e.g., protein levels declined by 39.5% in diaphragm mitochondria and by 44.2% in cardiac mitochondria; P < 0.001 and P = 0.009, respectively, comparing sepsis to control conditions). Our data indicate that endotoxin markedly impairs the MtCK-ATP transporter system; this phenomenon may have significant effects on diaphragm and cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916915     DOI: 10.1152/japplphysiol.01204.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  Hydrogen sulfide prevents diaphragm weakness in cecal ligation puncture-induced sepsis by preservation of mitochondrial function.

Authors:  Hai-Xia Zhang; Jun-Ming Du; Zhong-Nuo Ding; Xiao-Yan Zhu; Lai Jiang; Yu-Jian Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Critical diaphragm failure in sudden infant death syndrome.

Authors:  Pontus Max Axel Siren; Matti Juhani Siren
Journal:  Ups J Med Sci       Date:  2011-01-12       Impact factor: 2.384

4.  MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Lin Wang; Elizabeth A Schroder; Leigh Ann P Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-27       Impact factor: 5.464

Review 5.  Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly.

Authors:  Qun S Zang; Steven E Wolf; Joseph P Minei
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

Review 6.  Sepsis-induced myopathy.

Authors:  Leigh Ann Callahan; Gerald S Supinski
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

Review 7.  Mitochondria and energetic depression in cell pathophysiology.

Authors:  Enn Seppet; Marju Gruno; Ants Peetsalu; Zemfira Gizatullina; Huu Phuc Nguyen; Stefan Vielhaber; Manfred H P Wussling; Sonata Trumbeckaite; Odeta Arandarcikaite; Doreen Jerzembeck; Maria Sonnabend; Katharina Jegorov; Stephan Zierz; Frank Striggow; Frank N Gellerich
Journal:  Int J Mol Sci       Date:  2009-05-19       Impact factor: 6.208

8.  MitoQ administration prevents endotoxin-induced cardiac dysfunction.

Authors:  G S Supinski; M P Murphy; L A Callahan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-05       Impact factor: 3.619

9.  Mitoquinone mesylate (MitoQ) prevents sepsis-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Elizabeth A Schroder; Lin Wang; Andrew J Morris; Leigh Ann P Callahan
Journal:  J Appl Physiol (1985)       Date:  2021-07-01

10.  Sepsis-induced cardiac mitochondrial dysfunction involves altered mitochondrial-localization of tyrosine kinase Src and tyrosine phosphatase SHP2.

Authors:  Qun S Zang; Bobbie Martinez; Xiao Yao; David L Maass; Lisha Ma; Steven E Wolf; Joseph P Minei
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.